Cardiac myocyte KLF5 regulates body weight via alteration of cardiac FGF21

Cardiac metabolism affects systemic energetic balance. Previously, we showed that Krüppel-like factor (KLF)-5 regulates cardiomyocyte PPARα and fatty acid oxidation-related gene expression in diabetes. We surprisingly found that cardiomyocyte-specific KLF5 knockout mice (αMHC-KLF5−/−) have accelerat...

Full description

Saved in:
Bibliographic Details
Published inBiochimica et biophysica acta. Molecular basis of disease Vol. 1865; no. 9; pp. 2125 - 2137
Main Authors Pol, Christine J., Pollak, Nina M., Jurczak, Michael J., Zacharia, Effimia, Karagiannides, Iordanes, Kyriazis, Ioannis D., Ntziachristos, Panagiotis, Scerbo, Diego A., Brown, Brett R., Aifantis, Iannis, Shulman, Gerald I., Goldberg, Ira J., Drosatos, Konstantinos
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.09.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Cardiac metabolism affects systemic energetic balance. Previously, we showed that Krüppel-like factor (KLF)-5 regulates cardiomyocyte PPARα and fatty acid oxidation-related gene expression in diabetes. We surprisingly found that cardiomyocyte-specific KLF5 knockout mice (αMHC-KLF5−/−) have accelerated diet-induced obesity, associated with increased white adipose tissue (WAT). Alterations in cardiac expression of the mediator complex subunit 13 (Med13) modulates obesity. αMHC-KLF5−/− mice had reduced cardiac Med13 expression likely because KLF5 upregulates Med13 expression in cardiomyocytes. We then investigated potential mechanisms that mediate cross-talk between cardiomyocytes and WAT. High fat diet-fed αMHC-KLF5−/− mice had increased levels of cardiac and plasma FGF21, while food intake, activity, plasma leptin, and natriuretic peptides expression were unchanged. Consistent with studies reporting that FGF21 signaling in WAT decreases sumoylation-driven PPARγ inactivation, αMHC-KLF5−/− mice had less SUMO-PPARγ in WAT. Increased diet-induced obesity found in αMHC-KLF5−/− mice was absent in αMHC-[KLF5−/−;FGF21−/−] double knockout mice, as well as in αMHC-FGF21−/− mice that we generated. Thus, cardiomyocyte-derived FGF21 is a component of pro-adipogenic crosstalk between heart and WAT. [Display omitted] •Cardiomyocyte-specific KLF5 deletion accelerates diet-induced obesity.•KLF5 is a positive regulator of Med13 expression.•The proadipogenic effect of KLF5 relies also on non-MED13 mechanisms.•Cardiomyocyte KLF5 regulates systemic metabolism and adiposity via FGF21.
Bibliography:Department of Biochemistry, University of Iowa Carver College of Medicine, Iowa City, IA, USA
Conceptualization K.D., C.J.P.; Methodology, K.D., C.J.P., N.M.P., E.Z., I.D.K., P.N.; Validation, C.J.P., N.M.P.; Formal Analysis, C.J.P., N.M.P., M.J.J., E.Z., I.D.K., I.K.; Investigation, C.J.P, N.M.P., M.J.J., E.Z., I.K., I.D.K., D.A.S, B.R.B., and K.D.; Resources, K.D., I.J.G., G.I.S., I.A.; Writing - Original Draft, C.J.P., K.D.; Writing - Review & Editing, C.J.P., N.M.P., M.J.J., E.Z., I.K., I.D.K., P.N., I.A., G.I.S., I.J.G., K.D.; Supervision K.D.; Project administration, C.J.P., K.D.; Funding Acquisition, K.D, I.J.G., I.A., P.N.
Division of Endocrinology, Diabetes & Metabolism, NYU-Langone School of Medicine, New York, NY, USA.
Department of Medicine, Division of Endocrinology and Metabolism, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
AUTHOR CONTRIBUTIONS
Genecology Research Centre, School of Science and Engineering, University of the Sunshine Coast, Queensland, Australia, CSIRO Synthetic Biology Future Science Platform, Australian Institute for Bioengineering and Nanotechnology, School of Chemistry and Molecular Biosciences, University of Queensland, Queensland, Australia
Department of Biochemistry and Molecular Genetics and Robert H. Lurie Comprehensive Cancer Center Northwestern University, Chicago, IL
ISSN:0925-4439
1879-260X
DOI:10.1016/j.bbadis.2019.04.010